Dalton, Greiner, Hartman, Maher & Co’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,805
Closed -$1.47M 59
2021
Q1
$1.47M Sell
7,805
-4,652
-37% -$820K 1.16% 15
2020
Q4
$2.05M Sell
12,457
-807
-6% -$118K 0.43% 70
2020
Q3
$1.65M Buy
+13,264
New +$1.64M 0.27% 119

Other funds holding HCA

Dalton, Greiner, Hartman, Maher & Co's HCA Position: Q2 2021 in Review

Dalton, Greiner, Hartman, Maher & Co sold out of HCA Healthcare (HCA) in Q2 2021, closing a stake of 7,805 shares — an estimated $1.47M sold.

Dalton, Greiner, Hartman, Maher & Co first reported a position in HCA in Q3 2020 and held it in 3 quarters. The position peaked at $2.05M in Q4 2020. 823 funds tracked by Wall St. Rank hold HCA as of Q2 2021.

  • Dalton, Greiner, Hartman, Maher & Co reported no remaining HCA Healthcare position as of Q2 2021 after selling out during the quarter.
  • Dalton, Greiner, Hartman, Maher & Co sold 7,805 HCA Healthcare shares in Q2 2021, an estimated $1.47M.
  • Dalton, Greiner, Hartman, Maher & Co first reported a position in HCA Healthcare in Q3 2020 and held it in 3 quarters.
  • Dalton, Greiner, Hartman, Maher & Co's HCA Healthcare position peaked at $2.05M in Q4 2020.
  • 823 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2021.

Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q2 2021.